Featured
Health Topics
-
Chemicals and Drugs12
See more
- Amino Acids, Peptides, and Proteins 1
- Biological Factors 2
- Chemical Actions and Uses 1
- Complex Mixtures 1
- Enzymes and Coenzymes 3
- Heterocyclic Compounds 5
- Hormones, Hormone Substitutes, and Hormone Antagonists 2
- Inorganic Chemicals 1
- Nucleic Acids, Nucleotides, and Nucleosides 2
- Organic Chemicals 3
- Polycyclic Compounds 2
-
Diseases27
See more
- Bacterial Infections and Mycoses 3
- Cardiovascular Diseases 3
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities 4
- Digestive System Diseases 3
- Endocrine System Diseases 4
- Female Urogenital Diseases and Pregnancy Complications 5
- Hemic and Lymphatic Diseases 3
- Immune System Diseases 6
- Male Urogenital Diseases 3
- Musculoskeletal Diseases 4
- Neoplasms 8
- Nervous System Diseases 4
- Nutritional and Metabolic Diseases 1
- Occupational Diseases 1
- Parasitic Diseases 1
- Pathological Conditions, Signs and Symptoms 7
- Skin and Connective Tissue Diseases 1
- Stomatognathic Diseases 1
- Virus Diseases 6
- Wounds and Injuries 1
- Psychiatry and Psychology6 See more
Search Clinical Trials
Not Yet Recruiting
Toddler Biomarker of Nutrition Study (External Link)
Young children rely on their foods and drinks for the nutrients they need to grow, like energy, protein, vitamins, and minerals. However, it is challenging for researchers to study children's …
Baylor Role:
Lead Sponsor
Not Yet Recruiting
Allogeneic CD30 Chimeric Antigen Receptor Epstein-Barr Virus-Specific T Lymphocytes in Relapsed or Refractory CD30-Positive Lymphomas (External Link)
Earlier, healthy donors gave blood for us to make CD30.CAR-EBVST cells in the laboratory. These cells were grown and frozen and the investigators will select the donor which the investigators …
Baylor Role:
Lead Sponsor
Not Yet Recruiting
The Effects of Natesto For Treatment Of Hypogonadism (External Link)
Testosterone replacement therapy (TTh) is becoming increasingly common among men of reproductive age in the United States. An estimated 3 million men are on TTh; however exogenous testosterone use can …
Baylor Role:
Lead Sponsor
Not Yet Recruiting
OCD Biomarker Survey Employing sEEG and Stimulation: The OBSESS Trial (External Link)
Obsessive-compulsive disorder (OCD) has a lifetime prevalence of 2-3% and is a major cause of global disability. Deep brain stimulation (DBS) is an effective treatment for patients with severe, treatment-resistant …
Baylor Role:
Lead Sponsor
Not Yet Recruiting
A Multi-site Feasibility Clinical Trial of Retraining and Control Therapy (ReACT), a Mind and Body Treatment for Pediatric Functional Seizures (External Link)
This study aims to conduct a multi-site pilot feasibility Randomized Controlled Trial (RCT) at the University of Alabama at Birmingham, Yale College of Medicine/Yale New Haven Children's Hospital and Baylor …
Baylor Role:
Collaborator
Not Yet Recruiting
Left vs Left Randomized Clinical Trial (External Link)
In this prospective, randomized, multi-center clinical trial, the investigators aim to prospectively evaluate the comparative effectiveness His or Left bundle branch pacing (His/LBBP) vs. biventricular pacing (BiVP) in patients with …
Baylor Role:
Lead Sponsor
Not Yet Recruiting
Hydrogen's Safety and Efficacy as a Therapy in ECPR (External Link)
The purpose of this project is to test the feasibility and safety of inhaled hydrogen gas (H2) administration as a rescue therapy during cardiac arrest requiring extracorporeal cardiopulmonary resuscitation (ECPR, …
Baylor Role:
Collaborator
Not Yet Recruiting
Neoadjuvant Chemoimmunotherapy for Resectable Non-Metastatic Proficient Mismatch Repair (PMMR) Colon Cancer (External Link)
Once participants' eligibility has been confirmed, and participants have been registered in the study, the participants will receive immunotherapy treatment with Atezolizumab, followed by administration of CAPEOX chemotherapy for a …
Baylor Role:
Lead Sponsor
Not Yet Recruiting
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors (External Link)
Approximately 15-24 subjects will participate in the treatment part of this study. Maximum of 180 mL of blood (not exceeding 3ml/kg/day) is collected from patients to grow the T cells …
Baylor Role:
Lead Sponsor
Not Yet Recruiting
A Study of Total Neoadjuvant Chemotherapy With FLOT VS Standard Perioperative FLOT in Patients With Gastric or GEJ Cancer (External Link)
Participants will be randomized 1:1 to either total Neoadjuvant chemotherapy with with FLOT-TNT ( all 4 cycles of chemotherapy before surgery) or standard of care FLOT-POP ( 2 cycles of …
Baylor Role:
Lead Sponsor